Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:clinicalTrialPhase |
Phase I/II
|
| gptkbp:developedBy |
gptkb:Biomea_Fusion
|
| gptkbp:firstReported |
2021
|
| https://www.w3.org/2000/01/rdf-schema#label |
BMF-219
|
| gptkbp:indication |
gptkb:acute_myeloid_leukemia
gptkb:type_2_diabetes |
| gptkbp:mechanismOfAction |
covalent menin inhibitor
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:status |
investigational
|
| gptkbp:target |
menin protein
|
| gptkbp:bfsParent |
gptkb:Biomea_Fusion
|
| gptkbp:bfsLayer |
8
|